Cardiovascular, Breast Safety Study Of Libigel In Women With Hypoactive Sexual Desire Disorder

June 16th, 2008 | Category: Womens Health

Michael C. Snabes, MD, PhD, vice president of clinical development of BioSante Pharmaceuticals, will be presenting an overview of a key study in the LibiGel® (testosterone gel) development program at The

Endocrine Society’s 90th Annual Meeting in San Francisco at the Moscone Center on Sunday, June 15, 2008.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Women With Low Sexual Desire Benefit From Testosterone Patch
  • Silence Hinders Diagnosis Of The Prevalent Condition Hypoactive Sexual Desire Disorder(HSDD)
  • Sexual Dissatisfaction In Postmenopausal Women Not Linked To Cardiovascular Disease
  • Reduction In Sexual Satisfaction Is Not Associated With Cardiovascular Disease In Postmenopausal Women
  • Palatin Technologies, Inc. Reports Positive details From An At Home Study Of Pre And Postmenopausal Women With Female Sexual Arousal Disorder

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.